CAILOS HEALTH
DEAD

Serial Number

79199860

Owner

Caelus Pharmaceuticals B.V.

Filing Date

May 20, 2016

Add to watchlist:

No watchlists yet
View on USPTO

CAILOS HEALTH Trademark

Serial Number: 79199860

CAILOS HEALTH is a trademark filed by Caelus Pharmaceuticals B.V. on May 20, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

Caelus Pharmaceuticals B.V. (9 trademarks)

Rondweg 50

Entity Type: 98

Trademark Details

Filing Date

May 20, 2016

Registration Date

Not Registered

Goods & Services

Pharmaceutical products; dietetic foodstuffs and dietetic substances for medical use; food supplements for human beings; medical preparations and articles; diagnostic preparations for medical use; pharmaceutical products and natural medicines; vaccines; pharmaceutical preparations, including medicines and vaccines, for the prevention of diabetes mellitus, Crohn's disease and/or ulcerative colitis disease; pharmaceutical preparations, including medicines for the treatment of diabetes mellitus, Crohn's disease, ulcerative colitis disease and/or metabolic syndrome (insulin resistance); dietetic nutritional additives and dietetic preparations; dietetic nutritional additives and dietetic substances for the prevention of diabetes mellitus, Crohn's disease and/or ulcerative colitis disease; dietetic nutritional additives and dietetic substances for the treatment of diabetes mellitus, Crohn's disease, ulcerative colitis disease and/or metabolic syndrome (insulin resistance); cultures of microorganisms for medical use, including bacterial preparations; chemicals for the diagnosis of diabetes mellitus, Crohn's disease and/or ulcerative colitis disease; vaccine preparations for human use

Medical apparatus and instruments; diagnostic, testing and monitoring equipment; testing apparatus for medical use; measuring devices for medical use; testing apparatus for medical use, including blood testing apparatus, apparatus for analyzing faeces or respiratory gas analyzers, medical measuring devices for medical use, including devices for measuring microorganisms or gas; medical test kits for home monitoring of diabetes

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Dec 30, 2023 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 14, 2018 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Aug 23, 2018 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 23, 2018 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 22, 2018 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 6, 2018 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 6, 2018 OPNR
NEW REPRESENTATIVE AT IB RECEIVED
Dec 15, 2017 NREP
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Aug 23, 2017 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Aug 23, 2017 ABN2
REFUSAL PROCESSED BY IB
Feb 18, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 25, 2017 RFCS
REFUSAL PROCESSED BY MPU
Jan 25, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 21, 2017 RFCR
APPLICATION FILING RECEIPT MAILED
Jan 21, 2017 MAFR
NON-FINAL ACTION WRITTEN
Jan 20, 2017 CNRT
ASSIGNED TO EXAMINER
Jan 17, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 17, 2017 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jan 13, 2017 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 5, 2017 REPR